Back to Search Start Over

Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

Authors :
Ece Özoğul
Anna Montaner
Melina Pol
Gerard Frigola
Olga Balagué
Charlotte Syrykh
Pablo Bousquets-Muñoz
Romina Royo
Juliette Fontaine
Alexandra Traverse-Glehen
Marco M. Bühler
Luca Giudici
Marco Roncador
Thorsten Zenz
Sylvain Carras
Severine Valmary-Degano
Laurence de Leval
Jan Bosch-Schips
Fina Climent
Julia Salmeron-Villalobos
Melika Bashiri
Silvia Ruiz-Gaspà
Dolors Costa
Sílvia Beà
Itziar Salaverria
Eva Giné
Leticia Quintanilla-Martinez
Pierre Brousset
Mark Raffeld
Elaine S. Jaffe
Xose S. Puente
Cristina López
Ferran Nadeu
Elias Campo
Source :
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Publication Year :
2024
Publisher :
Nature Publishing Group, 2024.

Abstract

Abstract Mantle cell lymphoma (MCL) is genetically characterized by the IG::CCND1 translocation mediated by an aberrant V(D)J rearrangement. CCND1 translocations and overexpression have been identified in occasional aggressive B-cell lymphomas with unusual features for MCL. The mechanism generating CCND1 rearrangements in these tumors and their genomic profile are not known. We have reconstructed the IG::CCND1 translocations and the genomic profile of 13 SOX11-negative aggressive B-cell lymphomas using whole genome/exome and target sequencing. The mechanism behind the translocation was an aberrant V(D)J rearrangement in three tumors and by an anomalous IGH class-switch recombination (CSR) or somatic hypermutation (SHM) mechanism in ten. The tumors with a V(D)J-mediated translocation were two blastoid MCL and one high-grade B-cell lymphoma. None of them had a mutational profile suggestive of DLBCL. The ten tumors with CSR/SHM-mediated IGH::CCND1 were mainly large B-cell lymphomas, with mutated genes commonly seen in DLBCL and BCL6 rearrangements in 6. Two cases, which transformed from marginal zone lymphomas, carried mutations in KLF2, TNFAIP3 and KMT2D. These findings expand the spectrum of tumors carrying CCND1 rearrangement that may occur as a secondary event in DLBCL mediated by aberrant CSR/SHM and associated with a mutational profile different from that of MCL.

Details

Language :
English
ISSN :
20445385
Volume :
14
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Blood Cancer Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.bc32ff445d443efa40b812995ecadc9
Document Type :
article
Full Text :
https://doi.org/10.1038/s41408-024-01146-z